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Abstract
Previous research has shown that an antimicrobial peptide (AMP) of the myticin class C (Myt C) is the most abundantly
expressed gene in cDNA and suppressive subtractive hybridization (SSH) libraries after immune stimulation of mussel
Mytilus galloprovincialis. However, to date, the expression pattern, the antimicrobial activities and the immunomodulatory
properties of the Myt C peptide have not been determined. In contrast, it is known that Myt C mRNA presents an unusual
and high level of polymorphism of unidentified biological significance. Therefore, to provide a better understanding of the
features of this interesting molecule, we have investigated its function using four different cloned and expressed variants of
Myt C cDNA and polyclonal anti-Myt C sera. The in vivo results suggest that this AMP, mainly present in hemocytes, could be
acting as an immune system modulator molecule because its overexpression was able to alter the expression of mussel
immune-related genes (as the antimicrobial peptides Myticin B and Mytilin B, the C1q domain-containing protein MgC1q,
and lysozyme). Moreover, the in vitro results indicate that Myt C peptides have antimicrobial and chemotactic properties.
Their recombinant expression in a fish cell line conferred protection against two different fish viruses (enveloped and non-
enveloped). Cell extracts from Myt C expressing fish cells were also able to attract hemocytes. All together, these results
suggest that Myt C should be considered not only as an AMP but also as the first chemokine/cytokine-like molecule
identified in bivalves and one of the few examples in all of the invertebrates.
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Introduction
Antimicrobial peptides (AMPs) are small, gene-encoded cationic
peptides that constitute important innate immune effectors from
organisms spanning most of the phylogenetic spectrum [1,2].
AMPs have a broad range of actions against many microorganisms
[3,4], including viruses [5], and it is not usual to observe the
acquisition of resistance to bacterial strains by these molecules [6].
Moreover, constitutive and induced production of AMPs has been
reported, with various expression patterns depending on the
species, tissue and cell type and infection or inflammation state.
These natural antibiotics (41000 AMPs have been estimated in
multicellular organisms) exemplify the complexity and heteroge-
neity of the innate immune responses because they can directly kill
microbes and act as modifiers of innate and even adaptive immune
responses [7].
In marine invertebrates, which live in environments with an
abundance of potentially pathogenic microorganisms, AMPs are
the leading elements of the immune response. For instance, in
Mediterranean mussels (Mytilus galloprovincialis), which in compar-
ison with other bivalves have almost no massive mortality records,
several types of AMPs have been described, among them
defensins, mytilins and myticins [8,9,10].
Three different isoforms (A, B and C) of mussel myticins have
been described so far, with isoform C being the most expressed
transcript in adults; to our knowledge, it is the only known mussel
AMP expressed at larval stages [11,12]. Strikingly, although
antimicrobial specificity of Myt C has not been demonstrated, it
presents higher levels of RNA polymorphism than those
previously reported for any other mussel AMP [11]. However,
to date, little is known about how this variability is generated and
what role it plays in the mussel immune response. Likewise, it has
not yet been established whether there is any correlation between
Myt C RNA polymorphisms and Myt C protein variants. A
plausible hypothesis could be that the set of Myt C molecules
might constitute a pathogen recognition receptor (PRR) system
because sequence diversity is a key feature of a relatively small
number of effector molecules involved in self and non-self
recognition [12]. Nevertheless, further studies are needed to
confirm this hypothesis.
Inthiswork,we analyzed the invivo tissularand cellularexpression
patterns of Myt C at the mRNA and protein levels. By expressing a
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23140recombinant peptide of Myt C, we demonstrated for the first time its
potentialantiviralandimmunoregulatoryproperties.Altogether,our
results suggest that Myt C might play a significant role in the
molluscan immune response against pathogens and external
aggressions. Moreover, the activity of recombinant Myt C peptides
against fish viruses in fish cell lines also suggests that this AMP is
active across species; therefore, it might be used to enhance fish
defenses in stressful environments and as a model molecule for
improving the design of fish antimicrobial drugs.
Results
Tissue distribution and subcellular location of Myt C
mRNA and protein
In situ hybridization (ISH) assays (Figure 1) showed that
hemocytes were the mussel cells with the highest Myt C
expression. A hemocyte monolayer hybridized with a Myt C
antisense RNA probe is shown in Figure 1A. All of the cells were
not marked by the probe, which indicates that some hemocytes do
not express Myt C. When this technique was applied to different
mussel tissues, such as muscle, connective tissue, gonad and gills
(Figure 1C, E, G and I, respectively), the positive reaction was
detected mainly in circulating hemocytes.
Consistent with the Myt C RNA expression pattern, immuno-
cytochemical and immunohistochemical analysis using the sera
produced against the two Myt C partial sequence peptides also
showed that the hemocytes were the main source of mussel Myt C
peptide (Figure 2 and Figure S1, respectively). Notably, the highest
expression of Myt C was found in the hemocytes located in the gill
plicae base (Figure S1). However, according to the RNA and
protein expression patterns, Myt C expression seemed limited to
some granulocyte subtypes. Regarding the subcellular localization
of Myt C, a clear cytoplasmatic expression pattern associated with
vacuoles could be observed (Figure 2C, D, F).
In vitro recombinant expression of Myt C variants
The levels of expression of the recombinant variants of Myt C
(Myt Cc, Myt Cg, Myt Ck and Myt Ccon) were analyzed in vitro by
RT-qPCR and fluorescence microscopy after transfecting CHSE
cells with the corresponding plasmid constructs (Figure 3 and
Figure S2).
To evaluate the expression of recombinant Myt C at the
transcription level, the presence of cell transcripts containing the
eGFP sequence was used as a marker. All Myt C-GFP variants
were expressed at comparable levels but slightly lower than the
expression of GFP (Figure 3A).
In contrast, to analyze whether the subcellular location of the
recombinant Myt C was analogous to that observed in mussel
hemocytes in vivo (Figure 2), the GFP fluorescence expression
pattern was examined by fluorescence microscopy. GFP was
diffusely distributed in the cytoplasm and the nucleus of CHSE
cells transfected with pMCV 1.4-eGFP (Figure 3B, panel 1 and 3).
Addition of the Myt C cDNA sequence to the N-terminus of GFP
caused a relocalization of the fluorescence within the cells. Thus,
48 h after transfecting the CHSE cells with plasmids encoding the
Myt C variants fused to GFP, the bulk of the fluorescence
appeared in the perinuclear region (Figure 3B, panel 4 and 6 and
Figure S2) where the trans-Golgi network is usually located.
Moreover, nearly all of the cells exhibited a slight non-uniform
granulated cytoplasmic distribution of the fluorescence (Figure 3B,
panel 4 and 6 and Figure S2, panels 1, 4 and 7) and a peripheral
fluorescence pattern near the cellular membrane suggesting the
possibility of Myt C extracellular secretion. In contrast with the
CHSE cells expressing GFP alone, fluorescence was excluded from
the nuclear region in the Myt C-GFP-expressing CHSE cells. We
detected no effects of the Myt C expression on CHSE cell
morphology or viability, as shown in Figure 3B and Figures S2 and
S3. Likewise, those figures show that recombinant Myt C
expression did not induce apoptosis.
We observed no differences in the fluorescence pattern among
the four variants of Myt C-GFP (Figure S2).
Finally, further confirmation of the cytoplasmic location of
recombinant Myt C observed in vivo (Figure 2) was obtained by
labeling Myt C-GFP expressing cells with the antisera to Myt Cc.
As expected, both the GFP fluorescence (Figure S3 panel 1) and
immune staining patterns (Figure S3 panel 2) were coincident
(Figure S3 panel 4). Antisera to Myt Cc also recognized the Myt C
variants k, g and con (not shown).
Resistance of CHSE cells expressing the Myt C variants to
viral infections
To carry out the antiviral activity studies, CHSE cells were
transiently transfected with each of the plasmids encoding the Myt
C variants. Seventy-two hours after transfection, the CHSE cells
were infected, and Viral Hemorrhagic Septicaemia virus (VHSV)
and Infectious pancreatic necrosis virus (IPNV) infectivity was
determined 24 h later. The results showed $85% reduced VHSV
infectivity in CHSE cells transfected with Myt C variants c, g and
k and ,75% with Myt Ccon (Figure 4A). Control CHSE cells,
CHSE cells transfected with empty pMCV 1.4 or pMCV 1.4-
eGFP plasmids, propagated the virus almost as efficiently as non-
transfected CHSE cells because VHSV infectivity was not
significantly reduced (Figure 4A). These data revealed that CHSE
cells expressing Myt C had reduced susceptibility to VHSV. In
contrast, no significant reduction of IPNV infectivity in CHSE
cells expressing Myt C was observed, except in the cells expressing
the Myt Ccon (Figure 5A).
Furthermore, viral replication could not be detected in the cells
expressing the Myt C variants but was detected in the surrounding
non-expressing cells (Figures 4B and 5B, panels 5–8). In contrast,
both VHSV (Figure 4B, panels 1–4) and IPNV (Figure 5B, panels
1–4) viruses could be detected in the cells expressing eGFP alone.
In vivo recombinant expression of MytC
Among the four Myt C variants used in this work, the consensus
Myt C (Myt Ccon) was chosen for in vivo expression assays because it
was the only isoform that inhibited both VHSV and IPNV
infectivity in vitro. Myt C expression in hemocytes was observed after
the plasmid pMCV1.4-Myt Ccon-eGFP was injected into mussel
adductor muscle (Figure 6). After 72 h, mussels injected with
pMCV1.4-Myt Ccon-eGFP showed a significantly higher hemocy-
tic Myt C expression (p,0.05) comparedwiththe Myt C expression
observed in mussels injected with PBS and pMCV1.4 control.
Expression pattern of immuno-related genes induced by
the overexpression of recombinant Myt C in vivo
To investigate the potential immunoregulatory properties of Myt
C, the levels of expression of a set of immune-related genes were
analyzed by RT-qPCR in the hemocytes of mussels intramuscularly
injected with empty pMCV1.4 plasmid or pMCV1.4 Myt Ccon-
eGFP. Figure 7 shows the selected immune-related genes that have
significantly different levels of expression (p,0.05) compared with
controls. Two antimicrobial peptides (mytilin B and myticin B), the
C1q domain containing protein (MgC1q) and lysozyme had
significantly increased expression at 72 h in animals injected with
pMCV1.4 Myt Ccon. The expression of macrophage migration
inhibitory factor (MIF) also increased, but not significantly (data not
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also increased after injection with the pMCV1.4 empty plasmid
control (data not shown).
Chemotaxis
The recombinant Myt Cc elicited a chemotactic response from
hemocytes in the majority of mussels studied (75%). Importantly,
there was variability of the magnitude of the chemotactic response
among different individual mussels ranging from a 1.1 to a 134-
fold increase compared with the migration in control solutions
(Figure 8A). Therefore, we have presented values from individual
mussels instead of mean 6 SD. The hemocytes that migrated
through the cell insert to the Myt suspension exhibited a distinct
morphology (Figure 8B) compared with hemocyte migration in
control suspensions (Figure 8C); contained a higher number of
cytoplasmic granules.
Discussion
Due to the lack of adaptive immunity, AMPs play a key role in
the immune system of invertebrate organisms, such as mussels
[8,9,10]. Thus, mussels and other bivalves can be considered as an
interesting source of these innate immunity effector molecules, and
due to their wide range of antimicrobial action, AMPs could be
used to control infectious diseases that transcend a single aquatic
species or pathogen.
It has been recently reported that Mediterranean mussels (M.
galloprovincialis), that have experienced fewer mass mortalities than
other edible bivalves, have an AMP Myt isoform, Myt C, which is
highly polymorphic at the mRNA level [11,12]. Although it has
been suggested that the Myt C polymorphism could constitute a
molecular adaptation to the interaction of these peptides with the
surrounding pathogens [13], the exact role of Myt C has not been
clearly established. Therefore, this work was aimed at elucidating
the expression pattern of this interesting molecule and the
immunological role of Myt C, both as effector and modulator
molecule. First, we determined the in vivo tissular and cellular Myt
C expression patterns (Figures 1 and 2) at the transcriptional and
protein levels, using specific RNA probes and antisera to Myt C.
Both of the RNA and protein-based analyses showed that Myt C is
expressed in hemocytes, consistent with previously described
expression of other AMPs in invertebrates for other AMPs
[9,14,15]. In contrast, Myt C was not expressed in all mussel
hemocyte or tissues types, as was previously suggested for defensins
and mytilins [15,16]. Circulating hemocytes expressing Myt C
were observed in muscle, connective tissue, gonad and gills by ISH
Figure 1. Myt C expression in mussels at the mRNA level. ISH in hemocytes, muscle, connective tissue, gonad and gills from mussel using the
myticin antisense RNA probes (A, C, E, G and I, respectively). Control samples were hybridized with the sense probes (B, D, F, H and J, respectively).
Scale bar: 50 mm in all cases except in a and b (12.5 mm).
doi:10.1371/journal.pone.0023140.g001
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plicae base of the gills (Figure S1). Because mussels are filter-feeding
animals that can inhabit polluted locations and even feed on
bacteria [17,18], the gills are the first tissue to come in contact with
putative pathogens; the high presence of Myt C-expressing
hemocytes could suggest a role for this AMP in a fast immune
response.
Next, to investigate the potential antimicrobial activity of Myt
C, we cloned and expressed eGFP fusions of the four different
cDNA sequences of Myt C, including the previously determined
consensus sequence of the Myt C gene, in vitro. The complete
sequence of the Myt C prepropeptide was included in the plasmids
used to transfect the CHSE cells to assure that all of the
information required to process mature Myt C was present. The
levels of Myt C expression in transfected CHSE cells were quite
similar at both the RNA (Figure 3A) and protein levels for all of
the constructs studied (Figure 3B and Figure S2). However,
visualisation of the intracellular GFP fluorescence in living CHSE
cells expressing eGFP or the different Myt C-eGFP variants
(Figure 3B and Figure S2) showed that eGFP was homogeneously
present throughout the entire cell, but Myt C-eGFP had a different
subcellular localization. Overall, Myt C-eGFP was dispersed
throughout the cytoplasm of the cell with a slightly granular
appearance. This granular appearance of fluorescence suggests the
accumulation of the fusion protein inside vesicular structures along
the secretory pathway. This result is consistent with the in vivo Myt
C expression results (Figure 1 and 2) and previous reports that
mussel AMPs, defensin and mytilin, are localized to cytoplasmatic
granules [15,19]. The addition of eGFP to the C-terminus of Myt
C did not seem to modify the cellular expression pattern of this
AMP; this result was confirmed when Myt C-expressing cells were
stained with antisera to Myt C (Figure S3).
Because some reports have shown that AMPs possess antiviral
activity against enveloped and non-enveloped viruses [20,21], with
some of them acting across species [22,23], the antiviral activity of
recombinant Myt C was studied against the fish enveloped and
non-enveloped viruses, VHSV and IPNV, respectively. The results
clearly showed that Myt C could be considered as an invertebrate
antiviral immune effector, at least against the fish viruses that were
tested in this study. Notably, Myt C-transfected cells were more
resistant to VHSV infection than to IPNV infection, regardless of
the Myt C variant expressed by the cells (Figure 4A). In fact, only
the Myt Ccon variant was able to confer protection against IPNV
(Figure 4B). Therefore, enveloped viruses seem to be more
susceptible to Myt C because of the potential ability of this AMP to
disrupt lipid membranes, as it has been previously described for
other mussel AMPs, such as defensin and mytilin [10,24].
Furthermore, no viral replication could be observed in the CHSE
Myt C expressing cells (Figure 5), suggesting that Myt C expression
helped these cells to overcome viral infection. Moreover, very low
levels of VHSV replication could be detected in the CHSE Myt C-
expressing cells compared with the eGFP-transfected or non-
transfected cells, suggesting the induction of some protective effect
onthesurroundingcellsbytheexpressionofMytC,whichcould act
as a cytokine-like molecule. Alternatively, Myt C could be secreted
outside the expressing cells to inactivate the virus particles released
from the initially infected cells. Work is in progress to clarify the
mechanism underlying the antiviral activity of mussel Myt C.
In an attempt to investigate the potential immunomodulatory
properties of Myt C, mussels were transfected with a plasmid
Figure 2. Myt C expression in mussel hemocytes at the protein level. Control hemocytes without anti-Myticin sera but with secondary
antibody are presented in figures A and B. A positive reaction is detected by the deposition of brown deposits following DAB treatment (C, D, E and
F). Degranulation of hemocytes is indicated with arrowheads. The presence of myticin on vacuoles (at the surface or inside) is indicated with arrows.
Scale bars: 50 mm in A and E and 10 mm in B, C, D and F.
doi:10.1371/journal.pone.0023140.g002
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PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23140Figure 3. Recombinant expression of Myt C-eGFP variant C in CHSE cells. CHSE cells were transfected with pMCV1.4, pMCV1.4-eGFP or
pMCV1.4-Myt Cc-eGFP plasmids, and expression of eGFP and Myt Cc-eGFP was assessed 24 h later at the transcriptional and protein levels. A,
expression levels of transcripts of eGFP and Myt Cc-eGFP, Myt Cg-eGFP, Myt Ck-eGFP and Myt Ccon-eGFP evaluated by RT-qPCR using eGFP primers.
The data are presented as the mean 6 S.D. of two independent experiments, each performed in duplicate. a.u; arbitrary units. B, CHSE expressing
eGFP protein (upper panel) or Myt Cc-eGFP fusion protein (lower panel). CHSE micrographs at fluorescent (1,4); UV (2,5); (3,6) merged image of fields
1 and 2.
doi:10.1371/journal.pone.0023140.g003
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of several immune related genes were analyzed. It cannot be
ignored that the functionality of this consensus sequence could not
be 100%. Further research will detail the generation of this
variability and determine the relative importance of the different
isoforms in pathogen recognition and modulation of the immune
response. However, Myt Ccon was the only isoform that was
completely functional in antiviral experiments with the two viruses
analyzed in this study.
The overexpression of Myt Ccon induced significant changes in
the expression of Myticin B, MgC1q, Lysozyme and Mytilin B.
Myticin B is another member of the mussel myticin group that is
constitutively expressed in mussel hemocytes [25]. Myticin B is
expressed in hemocytes in virtually all mussel tissues and has
antibacterial activity against Gram-positive bacteria [15,26].
Mytilin B is a distinct antimicrobial peptide that is constitutively
expressed in adult mussels, and a decrease in the expression of this
gene is observed after bacterial challenge [8]. MgC1q is a
complement C1q domain-containing protein, recently character-
ized in M. galloprovincialis, which is highly induced after Gram-
positive or Gram -negative bacterial challenge [27]. MgC1q seems
to have the same properties as a pattern recognition receptor
Figure 4. Resistance of CHSE cells expressing the Myt C variants to VHSV infection. CHSE cells were non-transfected or transfected with
pMCV1.4, pMCV1.4-eGFP or with each of the pMCV1.4-Myt C-eGFP plasmids for 24 h, washed and then infected with VHSV for 2 h at 14uC. After
washing unbound virus, the infected cell monolayers were incubated for 24 h at 14uC, and viral infectivity was estimated by RT-qPCR. A, expression
levels of VHSV-pN in infected CHSE cells. The data are presented as the mean 6 S.D. from two independent experiments, each performed in triplicate.
Asterisks indicate significant differences (p,0.01) in viral infectivity relative to control cells (infected but non-transfected CHSE cells). B, VHSV
replication in CHSE-Myt C expressing cells. CHSE cells were transfected with pMCV1.4-eGFP (upper panel) or pMCV1.4-Myt Cc-eGFP (lower panel)
plasmids and infected with VHSV as above. Cell monolayers were then fixed and stained. 1 and 5 GFP fluorescence (green fluorescence); 2 and 6,
stained with the MAb I10 anti-G protein of VHSV and anti IgG-TRITC (red fluorescence); 3 and 7, stained with the Hoechst DNA stain (blue
fluorescence); 4 and 8, merged images.
doi:10.1371/journal.pone.0023140.g004
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molecule able to kill Gram-negative bacteria and also with
antifungal properties [30,31,32]. These data suggest that Myt C
not only has a role in the antiviral activities of mussels but could
also have modulator effects over different molecules: activating
and triggering the mussel innate immunity system both at
recognizing (MgC1q) and effector (lysozyme, myticin B) expression
levels. Non-specific changes in Macp and MMG1 expression could
be explained by unmethylated CpG motifs present in the vector
DNA, indicating that mussels are able to mount an immune
response against bacterial DNA, such as has been described both
in vertebrates and invertebrates [33,34,35].
Lysates from Myticin C-transfected cells induced significant cell
migration in individual mussels as compared with the lysates from
different controls. Chemotactic effects play a central role in the
inflammation process because they elicit the migration of cells to
the site of injury. Triggering chemotaxis is usually an important
mechanism for pathogen recognition by immune cells [36,37].
Molecules, such as opioid neuropeptides or TGF-b1 and PDGF-
AB, have shown chemotactic activity in Mytilus edulis [38,39]. In
the gastropod, Clithon retropictus, chemotaxis has been described as a
more efficient process in adult animals than in juveniles [36]. Myt
C is highly expressed in oocytes but is not expressed in the
spermatozoids of M. galloprovincialis [11], suggesting that this
chemotaxis could also have a role in reproduction. Hemocytes
chemotactically-induced by Myt C have abundant granules
present in the cytoplasm (Figure 8B) and have a distinct
morphology compared with treated control hemocytes, suggesting
Figure 5. Resistance of CHSE cells expressing the Myt C variants to IPNV infection. CHSE cells were non-transfected or transfected with
pMCV1.4, pMCV1.4-eGFP or with each of the pMCV1.4-Myt C-eGFP plasmids for 24 h, washed and then infected with VHSV for 2 h at 14uC. After
washing unbound virus, the infected cell monolayers were incubated for 24 h at 16uC, and viral infectivity was estimated by RT-qPCR. A, expression
levels of IPNV segment A in infected CHSE cells. The data are presented as the mean 6 S.D. from two independent experiments, each performed in
triplicate. Asterisks indicate significant differences (p,0.01) in viral infectivity relative to control cells (IPNV infected but non-transfected CHSE cells). B,
IPNV replication in CHSE-Myt C expressing cells. CHSE cells were transfected with pMCV1.4-eGFP (upper panel) or pMCV1.4-Myt Cc-eGFP (lower
panel) plasmids and infected with IPNV as above. Cell monolayers were then fixed and stained. 1 and 5 GFP fluorescence (green fluorescence); 2 and
6, stained with the MAb 2F12 anti-VP2 protein of IPNV and anti IgG-TRITC (red fluorescence); 3 and 7, stained with the Hoechst DNA stain (blue
fluorescence); 4 and 8, merged images.
doi:10.1371/journal.pone.0023140.g005
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homologous cytokines or chemokines in invertebrates, Myt C
could play the role of mediating immune activation because it
induces migration of particular hemocyte subtypes and triggers
hemocyte gene expression.
The high degree of nucleotide variability of Myt C sequences
has elicited questions regarding their function since they were first
described [12,13]. Here, we have studied expression of this AMP
and looked for antiviral, chemotactic and immunoregulatory
properties. Expression analysis at both the mRNA and protein
levels revealed that hemocytes were the main Myt C-expressing
cell type. Transfection analysis in the fish cell line, CHSE, revealed
that different isoforms of Myt C were mainly active against the
enveloped virus, VHSV, which is an important fish virus that
causes massive mortalities. In addition, transfection also revealed
that the cytomegalomovirus early promoter could direct the in vivo
expression of Myt C in mussels, resulting in an increase in the
expression of other immune-related genes in mussel hemocytes.
Recombinant Myt C also showed chemotactic activities in mussel
hemocytes. Together with the induction of the expression of
effector molecules, such as Myt B, Mytilin B and Lysozyme, this
data suggests its role as a cytokine in the mussel immune response.
Altogether, our results suggest that Myticin C might influence
the outcome of infection in the following ways: a) acting as direct
antiviral molecule, particularly against enveloped viruses, b)
inducing hemocyte chemotaxis and c) modulating the expression
of other immune genes that carry out and probably amplify the
mussel immune response.
Materials and Methods
Animals
Mediterranean mussels (M. galloprovincialis) were obtained during
low spring tide from wild populations. Animals were kept in an
Figure 6. Recombinant expression of Myt Cc-GFP in mussels.
Expression of Myt C following injection in adductor muscle of 2.5 mgo f
pMCV1.4 empty plasmid or pMCV1.4-Myt Ccon-eGFP. Control mussels
were injected with an equal volume of PBS. The results are represented
as mean 6 SD of three different biological replicates in a representative
experiment. Asterisks indicate significant differences (p,0.05) in Myt C
expression in mussels injected with pMCV1.4 empty plasmid (white
circles) or pMCV1.4-Myt Ccon-eGFP (black circles) relative to the
expression of PBS injected mussels, previously normalized to 18S
transcript levels.
doi:10.1371/journal.pone.0023140.g006
Figure 7. Expression pattern of immune-related genes induced by in vivo overexpression of recombinant Myt C. Expression of a
selected set of genes related to immune response in mussels. Mussels were injected in adductor muscle with 2.5 mg of pMCV1.4 empty plasmid or
pMCV1.4-Myt Ccon-eGFP. Control mussels were injected with an equal volume of PBS. The results represented as the mean 6 SEM of three different
biological replicates in a representative experiment. Asterisks indicate significant differences (p,0.05) in gene expression in mussels injected with
pMCV1.4 empty plasmid or pMCV1.4-Myt Ccon-eGFP relative to the expression of PBS-injected mussels, previously normalized to 18S transcript
levels. White bars, myt b; red bars, mgc1q; green bars, lysozyme and blue bars, mytilin b.
doi:10.1371/journal.pone.0023140.g007
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of the phytoplanktonic species Isochrysys galbana, Tetraselmis svecica
and Skeletonema costatum. Animals were acclimatized for at least one
week prior to the experiments. Molluscs care and experiments
were conducted according the CSIC National Committee on
Bioethics guidelines under approval number ID 20.03.11.
In situ hybridization
In situ hybridization (ISH) was carried out to localize the
expression of the myticin gene, as described in Murray et al. [40]
with minor modifications.
Probe preparation. Digoxigenin-labeled Myt C-specific
RNA probes, antisense (As) and sense (S; control) (GenBank
Accession Number JF323020), were prepared by in vitro
transcription of cDNA clones using the DIG RNA labeling kit
(SP6/T7) (Roche Diagnostics, Mannheim, Germany) according to
the manufacturer’s protocol.
Tissue in situ hybridization. Dorsoventral mussel sections
of 0.5 cm were fixed overnight at 4uC in 4% formalin solution and
manually dehydrated through an ethanol series, cleared in xylene
and embedded in paraffin for sectioning. Serial sections of 7 mm
were cut from the block and placed on polylysine-coated glass
slides (Thermo Scientific, Waltham, MA, USA), briefly air dried
and baked overnight at 60uC.
The ISH assays were performed simultaneously on two sets
(As and S) of duplicate slides, each one with serial sections from
the same animal. Briefly, deparaffinized, rehydrated tissue
sections equilibrated in fish saline [41] were pre-digested with
proteinase K (2.5 mgm l
21) and treated with the probes (50 ml)
diluted with in situ hybridization buffer at 47uCo v e r n i g h t .S l i d e s
were subsequently incubated with RNase A and RNase T1
buffer for 30 min at 37uC to eliminate non-hybridized probes
and washed in saline sodium citrate buffer (SSC). After
incubation with blocking buffer, digoxigenin was detected using
sheep anti-DIG-alkaline phosphatase-conjugated antibodies
(1:250) (Roche Diagnostics, Mannheim, Germany). Alkaline
phosphatase was detected using NBT (nitroblue tetrazolium)/
BCIP (5-bromo-4-chloro-3-indolyl-phosphate) (Roche Diagnos-
tics, Mannheim, Germany).
Hemocyte in situ hybridization. Detection of Myt C
expression in hemocytes was conducted with the probes
synthesized as described above. The hemocytes were collected
and immediately fixed in 5 volumes of 4% formalin solution. After
washing in 70% ethanol, hemocytes were placed in two sets (As
and S) of duplicate polylysine slides (Thermo Scientific, Waltham,
MA, USA) and centrifuged at 750 rpm for 5 min using a
cytocentrifuge (Cytospin 4 Cytocentrifuge, Thermo Scientific,
Waltham, MA, USA). Slides were washed with PBS for 10 min,
and hemocytes were permeabilized with proteinase K (4 mgm l
21)
at 37uC for 10 min. Hemocytes were then fixed in 4% cold
formaldehyde (10 min at 4uC), rinsed with 2X SSC and treated
with hybridization buffer for 90 min at 37uC in a humid
incubation chamber. Probes (50 ng per slide) were added to
slides and incubated overnight at 37uC on gene frames (Abgene,
Epsom, UK). After washing, digoxigenin was detected as
explained above.
Synthetic peptides from the sequence of Myt C cDNA
In silico translation (http://www.expasy.org) from the cDNA
sequence of a Myt C variant prepropeptide (Tables 1 and 2),
now called Myt Cc, was used for the synthesis of 13- and-16-
mer peptides, p13 and p16 (Table 1), respectively. Synthesis
was performed by New England Peptide (Gardner, MA, USA)
with a purity of .95%, as determined by high-performance
liquid chromatography and mass spectrophotometry. Peptides
were reconstituted to a final concentration of 1 mg ml
21 in
Milli Q water and stored in suitable aliquots at 280uCu n t i l
used.
Production of antiserum to Myt C in the rabbit
To obtain the antisera (New England Peptide, Gardner, MA,
USA), rabbits were first co-immunized with 1 mg ml
21 of each of
Figure 8. Chemotactic activity of Myt C. Chemotaxis of fresh hemocytes in response to lysates from CHSE transfected cells with pMCV1.4,
pMCV1.4-eGFP and pMCV 1.4-Myt Ccon-eGFP vector and CHSE non-transfected cells. Hemocytes from individual mussels were seeded in the upper
chamber and lysates from CHSE cells in the lower chamber. A. The number of migrating cells from representative individual mussels to the lower
chambers is expressed as the mean 6 SD of the cellular counting of five different microscopic fields, relative to hemocytes migrating to lower
chambers containing FSW. Asterisks denote statistically significant differences when comparing with CHSE non-transfected cells (p,0.01). B. Aspect
of representative hemocytes after migrating to the lower chamber containing pMCV 1.4-Myt Ccon-eGFP. C. Aspect of representative hemocytes after
migrating to the lower chamber containing control treatments. Scale Bar: 10 mm.
doi:10.1371/journal.pone.0023140.g008
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Freund’s complete adjuvant. Four weeks later, a second injection
with the same antigens in Freund’s incomplete adjuvant were
given. Blood was collected before injection (pre-immune serum)
and at 30 days after the second injection. The collected blood
sample was subsequently incubated for 2 hours (h) at 4uC and
centrifuged to obtain the serum. Finally, affinity purification of
antisera over each respective peptide column was carried out to
obtain two antisera with distinct immunoreactivity: anti-Myt C
p13 detected the Myt Cc mature peptide, and anti-Myt C p16
detected the Myt Cc propeptide sequence (Table 1).
Immunodetection of Myticin C
Immunohistochemical staining was performed using a mixture
(1:1) of the affinity purified antisera, anti-Myt Cc p13 and p16 on
paraffin embedded mussels fixed in Davidson’s fixative. After
deparaffination, peroxidase activity was suppressed with 3%
hydrogen peroxide in methanol for 4 min. Antigen exposition
was achieved using proteinase K treatment (20 mgm l
21) for
10 min. A blocking step was carried out in 1% bovine serum
albumin (BSA)-containing Tris-Buffered Saline with Tween-20
(TBST) for 1 h at room temperature. Then the mixture of antisera
to Myt Cc diluted 50-fold in 1% BSA-containing phosphate
Table 1. Sequence and relative position of synthetic peptides used in present study.
Peptide name Sequence to C-terminal Position (From aa to aa)
Myt Cc prepropeptide MKATILLAVVVAVIVGVQEAQSVACRSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSRAESPLALS
GSARNVNDKNNEMDNSPVMNEMENLDQEMDMF
1–100
p13 HPGKICYCLHCSR 48–60
p16 CSARNVNDKNNEMDNS 69–84
Mature Myt Cc QSVACRSYYCSKFCGSAGCSLYGCYLLHPGKICYCLHCSR 20–60
doi:10.1371/journal.pone.0023140.t001
Table 2. Sequences of primers and probes for RT-qPCR.
Target Primer Name Sequence (59. .39) Probe
Reference (accession
number)
Enhanced Green
Fluorescent Protein
egfp fw ATGGTGAGCAAGGGCGAGGAG [49]
egfp rv CCGCTTTACTTG TACAGCTCG
Protein N of VHSV NVHSV fw GACTCAACGGGACAGGAATGA TGGGTTGTTCACCCAGGCCGC [54]
NVHSV rv GGGCAATGCCCAAGTTGTT
Segment A of IPNV IPNV A segment fw TCTCCCGGGCAGTTCAAGT CCAGAACCAGGTGACGAGTAT
GAGGACTACAT
[55]
IPNV A segment rv CGGTTTCACGATGGGTTGTT
Myticin Cc myt Cc fw ATTTGCTACTGCCTTCATTG Present Work
myt C rv TCCATCTCGTTGTTCTTGTC
Elongation factor 1 a ef1-a fw ACCCTCCTCTTGGTCGTTTC GCTGTGCGTGACATGAGGCA [56]
ef1-a rv TGATGACACCAACAGCAACA
Mytimycin Precursor 1 MMG1 Mytimycin
Prec qPCR1 S
ACGGATGACGCTTTTGTTTG Present Work (FJ804479)
MMG1 Mytimycin
Prec qPCR1 As
GCAGTCCCAGCAATGTTTC
Macrophage migration
inhibitory factor
MIF qPCR1 S TACACCCAGACCAAATGATG Present Work (FL498330)
MIF qPCR 1 As TTCTCCTAATGCTCCAATACTG
Myticin B Myticin B qPCR 1S AATGTCTTCGTTGTTCCAG Present work (AF162336)
Myticin B qPCR 1As AATGCCAGTTTCACCTTG
MgC1q MgC1q qPCR 1S ATTTATGCGTTCACTTGGAC Present Work (FN563147)
MgC1q qPCR 1As ACACCGATTTTTGTGCTG
Lysozyme Mg Lysozyme qPCR 1S TGTCTGTCGCACTATTCTTC Present Work (AF334665)
Mg Lysozyme qPCR 1As AGTCCGCAACAAACATTC
Mytilin B Myt 4 TGAAGGCAGGAGTTATTCTGGC [8]
Myt 3 ACAACGAAGACATTTGCAGTAGC
Macp Macp PCRq-F AAGGTGGATGTTGGTTATGGAGAA Present Work (HQ709239)
Macp PCRq-R GCCCAATCAGGCATCATGTTA
doi:10.1371/journal.pone.0023140.t002
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overnight at 4uC. Myt C was detected by incubating the slides with
a peroxidase-conjugated goat anti-IgG rabbit antibody (Sigma
Chem. Co, St. Louis, MO, USA) diluted 500-fold in 1% BSA-
containing PBS for 2 h at room temperature. The peroxidase
activity was detected using SIGMAFAST
TM Diaminobenzidine
(DAB) tablets (Sigma Chem. Co, St. Louis, MO, USA). All of the
washing steps were conducted with PBS. Finally, the slides were
lightly counterstained with hematoxylin for 5 s and mounted in
Permount Slide Mounting Fluid.
To carry out the immunocytochemistry staining, 100 mlo f
mussel hemolymph were centrifuged (750 rpm, 5 min) in a
cytocentrifuge (Cytospin 4 Cytocentrifuge, Thermo Scientific,
Waltham, MA, USA). After acetone fixation, blocking and
immunostaining were carried out as indicated above.
The photographs from the previous sections (in situ hybridiza-
tion and immunodetection) were obtained with a DXM 1200
digital camera mounted on a Nikon Eclipse 80i light microscope
(Nikon instruments Inc., NY, USA).
Constructs and plasmids
The plasmids used were pMCV 1.4 (Ready-Vector, Madrid,
Spain) [42] and pGFP, which is 3.4 kbp in length (Clontech,
Mountain View, CA, USA) and contains the eGFP cDNA
sequence under the control of the cytomegalovirus early promoter
(CMV).
To obtain the pMCV1.4-Myt C constructs, several Myt C
cDNA sequences were synthesized at Biost (Montreal, Canada).
The variants are Myt Cc, Myt Cg, Myt Ck and Myt Ccon (Table
S1). Of note, the sequence of the so-called variant Myt Ccon is a
previously established consensus sequence of the Myt C gene [12].
Each of these synthetic nucleotide sequences was then cloned into
the pMCV1.4 plasmid digested with the restriction enzymes KpnI
and XbaI following standard procedures. To obtain the different
pMCV1.4-Myt C-eGFP constructs, the eGFP cDNA sequence
was first excised from the pGFP plasmid with the restriction
enzymes XbaI and BamHI and then subcloned into each of the
pMCV1.4-Myt C plasmids digested with the same enzymes. The
products were resolved on a 1% agarose gel, and the DNA bands
were extracted from the gel and purified using GeneClean (Bio
101, Vista, CA, USA).
Cell cultures and virus
The fish cell lines used in this work, CHSE-214 (Chinook
salmon embryo) and EPC (Epithelioma papulosum cyprinid), were
purchased from the American Type Culture Collection (ATCC
numbers CRL-1681 and CRL-2872, respectively). Both cell lines
were maintained at 20uC in a 5% CO2 atmosphere with RPMI-
1640 Dutch modified cell culture medium (Gibco, Invitrogen Co.,
Carlsbad, CA, USA) containing 10% fetal calf serum (FCS) (Sigma
Chem. Co, St. Louis, MO, USA), 1 mM pyruvate (Gibco,
Invitrogen Co., Carlsbad, CA, USA), 2 mM glutamine (Gibco,
Invitrogen Co., Carlsbad, CA, USA), 50 mgm l
21 gentamicin
(Gibco, Invitrogen Co., Carlsbad, CA, USA) and 2 mgm l
21
fungizone (Gibco, Invitrogen Co., Carlsbad, CA, USA).
Viral hemorrhagic septicemia virus strain 07.71 (VHSV07.71)
was isolated in France from rainbow trout (Oncorhynchus mykiss)
[43] and propagated in the EPC cell line at 14uCa sp r e v i o u s l y
reported [44]. Infectious necrosis pancreatic virus (IPNV)
serotype sp., purchased from the American Type Culture
Collection (ATCC number VR-1318), was propagated in the
CHSE-214 cell line at 16uC as previously described [45]. In both
cases, supernatants from infected cell monolayers were clarified
by centrifugation at 4000 g during 30 min and kept in aliquots at
270uC. Clarified supernatants were used for the experiments.
The VHSV and IPNV stocks were titrated in 96-well plates using
a previously developed immunostaining focus assay (focus
forming units, f.f.u.) [22,46,47] and the end-point dilution
method [48], respectively.
Transfection assays
CHSE-214 cells were transfected with the empty plasmid
pMCV 1.4 or with plasmids encoding eGFP or the different Myt
C-eGFP sequences. Cell transfections were carried out as
described previously [49,50,51]. Briefly, CHSE-214 monolayers
were detached using TrypLE
TM Select (Gibco, Invitrogen Co.,
Carlsbad, CA, USA), resuspended in RPMI-1640 Dutch-modified
cell culture medium with 10% FBS and dispensed into 96-well
plates (4610
4 cells per well) in a final volume of 100 ml. Then,
0.2 mg of each plasmid, complexed with 0.3 ml of FuGene HD
(Roche Diagnostics, Mannheim, Germany), were added to each
well, and the plates were incubated at 20uC for 3 days. Myt C-
eGFP-transfected cells were viewed and photographed with an
inverted fluorescence microscope (Nikon Eclipse TE2000-U,
Nikon instruments Inc., NY, USA) provided with a digital camera
(Nikon DS-1QM).
Analysis of Myt C expression in transfected cells
The expression of Myt C variants in CHSE transfected cells was
analyzed at both the transcriptional and protein levels by
quantitative real time RT-PCR (RT-qPCR) and immunofluores-
cence (IF), respectively.
Because Myt C variants were expressed as fusion proteins with
eGFP, the expression of eGFP was used as marker to evaluate their
transcriptional levels. RT-qPCR was used to evaluate the
expression levels of the eGFP transcripts using eGFP cDNA-
specific primers (Table 2) and SYBR Green (Applied Biosystems,
Foster City, CA, USA).
To detect Myt C peptides, CHSE cells expressing Myt C-eGFP
fusion proteins were grown in 96–well plates, fixed with BD
Cytofix (BD Biosciences, Franklin Lakes, NJ, USA) for 15 min at
room temperature and permeabilized with 0.2% Triton X100
(Merck, Darmstadt, Germany) for 5 min at room temperature.
Cell monolayers were then incubated with the mixture (1:1) of the
affinity purified sera anti-Myt Cc diluted 300-fold in 0.1% BSA-
containing PBS for 2.5 h at room temperature. Using goat anti-
rabbit antibody conjugated to rhodamine (TRITC, Sigma Chem.
Co, St. Louis, MO, USA), the indirect staining was carried out.
Finally, to visualize cell nuclei, cell monolayers were incubated
with 0.1 mg ml
21 of the Hoechst DNA stain (Sigma Chem. Co,
St. Louis, MO, USA) for 10 min. Immunostained cells were
viewed and photographed with an inverted fluorescence micro-
scope (Nikon Eclipse TE2000-U, Nikon instruments Inc., NY,
USA) provided with a digital camera (Nikon DS-1QM).
Viral infection assays
Transfected CHSE cells were washed extensively with PBS and
infected with VHSV or IPNV (multiplicity of infection, m.o.i. of
2610
22) in a final volume of 100 ml/well of culture medium
supplemented with 2% FCS for 2 h at 14uC. The infected cell
monolayers were then washed, fresh medium was added, and
plates were further incubated for 24 h. Viral replication in CHSE
cells was evaluated by RT-qPCR using the specific primer and
probe sequences for the gene encoding the N protein of VHSV or
for the segment A of the IPNV genome (Table 2). Non-transfected
CHSE cells that were infected with VHSV or IPNV were included
as control.
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analysis
Mussels were injected in the adductor muscle with either PBS or
with 2.5 mgm l
21 of empty plasmid pMCV1.4 or pMCV1.4-Myt
Ccon plasmids in a volume of 50 ml. Twenty four, 48 and 72 h
post-injection, hemolymph was withdrawn from the adductor
muscle of each animal with a disposable syringe, and hemocytes
were collected by centrifugation at 12000 g for 10 min and
subjected to subsequent RNA extraction.
Chemotaxis assay
Chemotactic properties of the recombinant Myt C were
determined using PET cell culture inserts of 8.0 mm pore size
(Becton & Dickinson, Franklin Lakes, NJ, USA) in 24-well plates.
Briefly, 250 ml of hemolymph from individual mussels (n=12)
was added to the upper compartment, and 400 ml of dilutions of
cell extracts were located in the lower compartment. These
extracts contained the cellular lysates of CHSE cells transfected
with pMCV1.4, pMCV1.4-GFP or pMCV1.4-Myt Cc-eGFP,
non transfected CHSE or filtered seawater (FSW). To obtain the
extracts, the cells were resuspended in FSW, frozen, thawed and
then centrifuged to eliminate cell debris. After 4 h of incubation
in the dark at 15uC, cells in the lower compartment were
recovered, subjected to cytocentrifugation as described above and
stained using the Hemacolor kit (Merck, Darmstadt, Germany)
according to the manufacturer’s instructions. Cells in the lower
chamber were counted using a Nikon Eclipse 80i light
microscope.
RNA isolation and cDNA synthesis
The RNeasy Plus Mini Kit (Qiagen, Hilden, Germany) was
used to extract total RNA from the CHSE cells following the
manufacturer’s instructions. The synthesis of cDNA from 1 mgo f
RNA, as estimated by a NanoDrop spectrophotometer 200 c
(Thermo Scientific, Waltham, MA, USA), was carried out using
M-MLV reverse transcriptase (Invitrogen Co., Carlsbad, CA,
USA) as previously described [22].
RNA from mussel cells was extracted with Trizol (Invitrogen
Co., Carlsbad, CA, USA) according to manufacturer’s instruc-
tions. Contaminating genomic DNA was removed using DNAse I
(Ambion, Applied Biosystems, Foster City, CA, USA). The
synthesis of cDNA from 1 mg of RNA was carried out using the
SuperScriptH III First-Strand Synthesis SuperMix for qRT-PCR
(Invitrogen Co., Carlsbad, CA, USA).
Real Time Quantitative PCR assays
Quantitative PCR in real time (RT-qPCR) was carried out as
previously described [22]. All reactions were performed in a 20-ml
volume containing 2 ml of the cDNA reaction, 900 nM of each
primer, 200 nM of probe and 10 ml of TaqMan Universal PCR
Master Mix (Applied Biosystems, Foster City, CA, USA). The
cycling conditions were 50uC for 2 min and 95uC for 10 min
followed by 40 cycles of 95uC for 15 s and 60uC for 1 min. Gene
expression results were analyzed by the 2
2DDCt method [52].
To evaluate the eGFP expression, the cellular elongation factor
1 alpha (EF1-a) gene (Table 2) was used as an endogenous control
for quantification. The control cells (non-transfected CHSE group)
served as the calibrator cells, and fold increases were calculated
relative to the level for these cells.
To evaluate virus replication, the internal reference for
normalization of data was the cellular 18S rRNA (Applied
Biosystems, Foster City, CA, USA). Viral infectivity results were
expressed as percentages of infectivity and calculated using the
formula (viral infectivity in transfected cells/viral infectivity in
non-transfected cells)6100.
To detect gene expression in mussel hemocytes, specific PCR
primers (Table 2) were designed and checked for hairpin and
dimer formation according to known RT-qPCR restrictions (PCR
product size, Tm difference between primers, GC content and self-
dimer or cross-dimer formation) with the Oligo Analyzer program,
version 1.0.2 (T. Kuulasma, University of Kuopio, Kuopio,
Finland, http://molbiol-tools.ca/OASetup102.exe). Then, the
efficiency of the primer pairs was analyzed with seven, five-fold
serial dilutions of cDNA and calculated from the slope of the
regression line of Cts versus the relative concentration of cDNA
[53]. A melting curve analysis was also performed to verify that no
primer dimers were amplified. If these conditions were not
accomplished, new primer pairs were designed. Mytimycin
precursor 1 (MMG1), Macrophage migration inhibitory factor
(MIF), Myticin B, Mytilus galloprovincialis C1q domain containing
protein (MgC1q), Lysozyme, Mytilin B and membrane attack
complex protein (Macp) were investigated for changes in gene
expression. One microliter of 10-fold diluted cDNA template was
mixed with 0.5 ml of each primer (10 mM) and 12.5 ml of SYBR
green PCR master mix (Applied Biosystems, Foster City, CA,
USA) in a final volume of 25 ml. The standard cycling conditions
were 95uC for 10 min, followed by 40 cycles of 95uC for 15 s and
60uC for 1 min. All reactions were carried out as technical
triplicates. The relative expression levels of the genes were
normalized using the 18S gene as a housekeeping gene, which
was constitutively expressed and not affected by Myt C
overexpression, following the Pfaffl method [53]. Fold change
units were calculated by dividing the normalized expression values
of the hemocytes from pMCV 1.4 empty plasmid or the
pMCV1.4-Myt Ccon-GFP injected mussels by the normalized
expression values of the controls.
Statistical analysis
To analyze the viral infectivity results, statistical comparisons
were made using a paired, two-tailed Student t test. To analyze
differences in gene expression among mussels injected with
pMCV1.4, pMCV1.4-Myt or PBS, statistical comparisons were
made using a one-tailed Student t-test considering groups of equal
variance. The results were expressed as mean 6 SEM (square
error of the mean), and differences were considered statistically
significant when p,0.05. Statistically significant differences in
chemotactic properties were determined using a one-tailed
Student t-test considering groups of equal variance against control
groups. Differences were considered statistically significant when
p,0.01.
Supporting Information
Figure S1 Immunohistochemical determination of the
expression pattern of Myt C in gills. Positive hybridization is
detected by brown deposits following DAB treatment in A
(arrowheads). Control tissues not hybridized with anti-Myticin
sera are presented in figure B. Scale bars: 25 mm.
(TIF)
Figure S2 Recombinant expression of Myt C-eGFP
variants in CHSE cells as eGFP fusion proteins. CHSE
cells were transfected with pMCV1.4-Myt Cg-eGFP, pMCV1.4-
Myt Ck-eGFP or pMCV1.4-Myt Ccon-eGFP plasmids and
assessed 24 h later. CHSE micrographs with fluorescent (1, 4
and 7) and UV light (2, 5 and 8); merged image of fields 1 and 2
(3), 4 and 5 (6) and 7 and 8 (9), respectively.
(TIF)
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localization of recombinant Myt Cc. Description of data:
CHSE cells were transfected with pMCV1.4-Myt Cc-eGFP
plasmid and 24 h post transfection washed, fixed and stained
with an antiserum anti-Myt C (1), GFP (2) Rho (3) UV (4) merged
image of fields 1, 2 and 3.
(TIF)
Table S1 Nucleotide sequences of Myt C variants and the
antisense ISH RNA cDNA template used in this study.
(DOCX)
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